Tuesday, May 20, 2014

Dilated Cardiomyopathy Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Dilated cardiomyopathy is a clinical condition in which primarily heart’s left ventricular considered to be the main pumping chamber is affected where it becomes enlarged unable to pump blood to the body. If proper measures are not taken then the problem often spreads to the right ventricle and then to the atria as the disease gets worse. Dilated cardiomyopathy also can lead to heart valve problems, arrhythmias (irregular heartbeats) and blood clots in the heart.Dilated cardiomyopathy may affect people of all ages, including infants and children. The treatments available especially focus on underlying cause of dilated cardiomyopathy, to improve blood flow and reduce other symptoms. Dilated cardiomyopathy’s drug therapy includes Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers, beta blockers, diuretics, Aldosterone antagonists, digitalis and anticoagulants. While implantable devices used to treat dilated cardiomyopathy includes biventricular pacemakers, implantable cardioverter-defibrillators (ICDs) and heart pumps (left ventricular assist devices).

The major causes of dilated cardiomyopathy are genetics, birth defects, infections, drug and alcohol abuse, certain cancer medications and exposure to toxins like lead, mercury and cobalt. In case of dilated cardiomyopathy, male patients are more prone to it than female patients, ratio is approximately 3:1. According to American Stroke Association, dilated cardiomyopathy is the most common form of cardiomyopathy and accounts for approximately 55 to 60% of all childhood cardiomyopathies. According to the pediatric cardiomyopathy registry database, this form of myopathy is detected in roughly 1 to 2 per 200,000 children with roughly one new case per 160,000 children reported each year in the United States.
The companies involved in the dilated cardiomyopathy therapeutics clinical trials areAastrom Biosciences, Inc., t2cure GmbH, Zensun (Shanghai) Sci& Tech Co., Ltd., Kasiak Research Pvt. Ltd., MyoKardia, Inc. and Capricor Therapeutics, Inc.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
·         It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments.

About Us:-
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information.

Contact Us:
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse Market Research Report:-


Post a Comment